Potential utility of pretreatment serum miRNAs for optimal treatment selection in advanced high-grade serous ovarian cancer.
Uehara T, Matsuzaki J, Yoshida H, Ogawa Y, Miura J, Fujimiya H, Yamamoto Y, Kawauchi J, Takizawa S, Yonemori K, Sakamoto H, Kato K, Ishikawa M, Ochiya T.
Uehara T, et al. Among authors: ishikawa m.
Jpn J Clin Oncol. 2024 Apr 22:hyae051. doi: 10.1093/jjco/hyae051. Online ahead of print.
Jpn J Clin Oncol. 2024.
PMID: 38651188